- Home
- IBIO
IBIO
iBio Inc.
as of 12-12-2025 3:46pm EST
$1.90
$0.52
-21.49%
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Chart Type:
Time Range:
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 16.4M | IPO Year: | N/A |
| Target Price: | $4.50 | AVG Volume (30 days): | 12.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.56 - $6.89 | Next Earning Date: | 11-12-2025 |
| Revenue: | $500,000 | Revenue Growth: | 185.71% |
| Revenue Growth (this year): | -61.75% | Revenue Growth (next year): | 11.11% |
AI-Powered IBIO Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 77.40%
77.40%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest iBio Inc. News
IBIO Breaking Stock News: Dive into IBIO Ticker-Specific Updates for Smart Investing
Compare IBIO vs Leading Stocks
See how IBIO stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IBIO iBio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.